PortalPublikationenTreatment of osteochondritis dissecans of the femoral condyl...

Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes.

Standard

Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes. / Steinhagen, Joern; Bruns, Juergen; Deuretzbacher, Georg; Rüther, Wolfgang; Fuerst, Martin; Niggemeyer, Oliver.

in: INT ORTHOP, 2009.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Steinhagen, J, Bruns, J, Deuretzbacher, G, Rüther, W, Fuerst, M & Niggemeyer, O 2009, 'Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes.', INT ORTHOP. <http://www.ncbi.nlm.nih.gov/pubmed/19626325?dopt=Citation>

APA

Steinhagen, J., Bruns, J., Deuretzbacher, G., Rüther, W., Fuerst, M., & Niggemeyer, O. (2009). Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes. INT ORTHOP. http://www.ncbi.nlm.nih.gov/pubmed/19626325?dopt=Citation

Vancouver

Steinhagen J, Bruns J, Deuretzbacher G, Rüther W, Fuerst M, Niggemeyer O. Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes. INT ORTHOP. 2009.

Bibtex

@article{bf72b91fabc74abc8ac3be5eae1a9578,
title = "Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes.",
abstract = "The objective of this study was to determine the clinical outcome of combined bone grafting and matrix-supported autologous chondrocyte transplantation in patients with osteochondritis dissecans of the knee. Between January 2003 and March 2005, 21 patients (mean age 29.33 years) with symptomatic osteochondritis dissecans (OCD) of the medial or lateral condyle (grade III or IV) of the knee underwent reconstruction of the joint surface by autologous bone grafts and matrix-supported autologous chondrocyte transplantation. Patients were followed up at three, six, 12 and 36 months to determine outcomes by clinical evaluation based on Lysholm score, IKDC and ICRS score. Clinical results showed a significant improvement of Lysholm-score and IKDC score. With respect to clinical assessment, 18 of 21 patients showed good or excellent results 36 months postoperatively. Our study suggests that treatment of OCD with autologous bone grafts and matrix-supported autologous chondrocytes is a possible alternative to osteochondral cylinder transfer or conventional ACT.",
author = "Joern Steinhagen and Juergen Bruns and Georg Deuretzbacher and Wolfgang R{\"u}ther and Martin Fuerst and Oliver Niggemeyer",
year = "2009",
language = "Deutsch",
journal = "INT ORTHOP",
issn = "0341-2695",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes.

AU - Steinhagen, Joern

AU - Bruns, Juergen

AU - Deuretzbacher, Georg

AU - Rüther, Wolfgang

AU - Fuerst, Martin

AU - Niggemeyer, Oliver

PY - 2009

Y1 - 2009

N2 - The objective of this study was to determine the clinical outcome of combined bone grafting and matrix-supported autologous chondrocyte transplantation in patients with osteochondritis dissecans of the knee. Between January 2003 and March 2005, 21 patients (mean age 29.33 years) with symptomatic osteochondritis dissecans (OCD) of the medial or lateral condyle (grade III or IV) of the knee underwent reconstruction of the joint surface by autologous bone grafts and matrix-supported autologous chondrocyte transplantation. Patients were followed up at three, six, 12 and 36 months to determine outcomes by clinical evaluation based on Lysholm score, IKDC and ICRS score. Clinical results showed a significant improvement of Lysholm-score and IKDC score. With respect to clinical assessment, 18 of 21 patients showed good or excellent results 36 months postoperatively. Our study suggests that treatment of OCD with autologous bone grafts and matrix-supported autologous chondrocytes is a possible alternative to osteochondral cylinder transfer or conventional ACT.

AB - The objective of this study was to determine the clinical outcome of combined bone grafting and matrix-supported autologous chondrocyte transplantation in patients with osteochondritis dissecans of the knee. Between January 2003 and March 2005, 21 patients (mean age 29.33 years) with symptomatic osteochondritis dissecans (OCD) of the medial or lateral condyle (grade III or IV) of the knee underwent reconstruction of the joint surface by autologous bone grafts and matrix-supported autologous chondrocyte transplantation. Patients were followed up at three, six, 12 and 36 months to determine outcomes by clinical evaluation based on Lysholm score, IKDC and ICRS score. Clinical results showed a significant improvement of Lysholm-score and IKDC score. With respect to clinical assessment, 18 of 21 patients showed good or excellent results 36 months postoperatively. Our study suggests that treatment of OCD with autologous bone grafts and matrix-supported autologous chondrocytes is a possible alternative to osteochondral cylinder transfer or conventional ACT.

M3 - SCORING: Zeitschriftenaufsatz

JO - INT ORTHOP

JF - INT ORTHOP

SN - 0341-2695

ER -